FDA授予快速通道指定-话题@MedSci

#FDA授予快速通道指定#

4篇内容 | 538人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1993730, encodeId=8c1e1993e30a9, content=<a href='/topic/show?id=51c0e3164b' target=_blank style='color:#2F92EE;'>#FDA授予快速通道指定#</a>, objectTitle=Blaze Bioscience的光学成像剂BLZ-100用于"点亮"儿童中枢神经系统肿瘤，获FDA授予快速通道指定, objectType=article, longId=191725, objectId=4cf9191e258a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cf9191e258a, replyNumber=0, likeNumber=42, createdTime=2021-03-23, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cf9191e258a, moduleTitle=Blaze Bioscience的光学成像剂BLZ-100用于"点亮"儿童中枢神经系统肿瘤，获FDA授予快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cf9191e258a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993732, encodeId=64e91993e32ce, content=<a href='/topic/show?id=51c0e3164b' target=_blank style='color:#2F92EE;'>#FDA授予快速通道指定#</a>, objectTitle=和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤, objectType=article, longId=192484, objectId=fb0c19248469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb0c19248469, replyNumber=0, likeNumber=40, createdTime=2020-05-06, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb0c19248469, moduleTitle=和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb0c19248469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993731, encodeId=23c71993e31f7, content=<a href='/topic/show?id=51c0e3164b' target=_blank style='color:#2F92EE;'>#FDA授予快速通道指定#</a>, objectTitle=非阿片类镇痛药EC5026治疗神经性疼痛：获得FDA授予快速通道指定, objectType=article, longId=192008, objectId=3c4019200808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4019200808, replyNumber=0, likeNumber=35, createdTime=2020-04-29, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4019200808, moduleTitle=非阿片类镇痛药EC5026治疗神经性疼痛：获得FDA授予快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c4019200808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993729, encodeId=15e31993e29d1, content=<a href='/topic/show?id=51c0e3164b' target=_blank style='color:#2F92EE;'>#FDA授予快速通道指定#</a>, objectTitle=Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定, objectType=article, longId=163663, objectId=4f8916366308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8916366308, replyNumber=0, likeNumber=32, createdTime=2019-06-15, rootId=0, userName=yige2004, userId=66962500501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8916366308, moduleTitle=Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8916366308)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA授予快速通道指定

2020-05-29

yige2004 (审核中...)

前往app查看评论内容

#FDA授予快速通道指定#

Blaze Bioscience的光学成像剂BLZ-100用于"点亮"儿童中枢神经系统肿瘤，获FDA授予快速通道指定

2021-03-23

yige2004 (审核中...)

前往app查看评论内容

#FDA授予快速通道指定#

和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤

2020-05-06

yige2004 (审核中...)

前往app查看评论内容

#FDA授予快速通道指定#

非阿片类镇痛药EC5026治疗神经性疼痛：获得FDA授予快速通道指定

2020-04-29

yige2004 (审核中...)

前往app查看评论内容

#FDA授予快速通道指定#

Immunocore的tebentafusp治疗转移性葡萄膜黑色素瘤被FDA授予快速通道指定

2019-06-15

科室
- - 订阅+
  - 更多科室
工具
服务